Report Open Access

Statistical review of Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

Kahan, Brennan; Hood, Kerry; Dahly, Darren


GeoJSON Export

{
  "type": "FeatureCollection", 
  "features": []
}
375
105
views
downloads
All versions This version
Views 375375
Downloads 105105
Data volume 21.4 MB21.4 MB
Unique views 347347
Unique downloads 100100

Share

Cite as